CNSP ▲ +3.5% - CNS Pharmaceuticals, Inc. $CNSP - CNS Pharmaceuticals Details Business Development Strategy Driving Its Next Phase of Growth CNS Pharmaceuticals shares rose 3.5% today following the company's announcement of its business development strategy for the next phase of growth. The disclosure of a strategic plan to drive future expansion appears to have resonated with investors seeking visibility into the company's path forward. 01-SEP-2026 09:06 AM ET